ACBD7 | Acyl-CoA binding domain containing 7 | | | | | | Tissue enriched |
ACTL6B | Actin-like 6B | | | | | | Tissue enriched |
ADCY1 | Adenylate cyclase 1 (brain) | Cancer-related genes Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
AK5 | Adenylate kinase 5 | Enzymes
| | | | | Tissue enriched |
AMER2 | APC membrane recruitment protein 2 | | | | | | Tissue enriched |
AMER3 | APC membrane recruitment protein 3 | | | | | | Tissue enriched |
AMPH | Amphiphysin | Cancer-related genes
| | | | | Tissue enriched |
ANKRD34A | Ankyrin repeat domain 34A | | | | | | Tissue enriched |
APC2 | Adenomatosis polyposis coli 2 | | | | | | Tissue enriched |
APLP1 | Amyloid beta (A4) precursor-like protein 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ARNT2 | Aryl-hydrocarbon receptor nuclear translocator 2 | Transcription factors
| | | | | Tissue enriched |
ASCL1 | Achaete-scute family bHLH transcription factor 1 | Predicted secreted proteins Transcription factors
| | | | | Tissue enriched |
ASIC1 | Acid-sensing (proton-gated) ion channel 1 | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
ATCAY | Ataxia, cerebellar, Cayman type | Disease related genes
| | | | | Tissue enriched |
ATP1B2 | ATPase, Na+/K+ transporting, beta 2 polypeptide | Predicted membrane proteins
| | | | | Tissue enriched |
ATP6V1G2 | ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 | | | | | | Tissue enriched |
B3GAT1 | Beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
B3GAT2 | Beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S) | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
B4GALNT1 | Beta-1,4-N-acetyl-galactosaminyl transferase 1 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
BAALC | Brain and acute leukemia, cytoplasmic | | | | | | Tissue enriched |
BAI2 | Brain-specific angiogenesis inhibitor 2 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
BAI3 | Brain-specific angiogenesis inhibitor 3 | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
BCAN | Brevican | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
BEND6 | BEN domain containing 6 | | | | | | Tissue enriched |
BRINP1 | Bone morphogenetic protein/retinoic acid inducible neural-specific 1 | Predicted secreted proteins
| | | | | Tissue enriched |
BRSK1 | BR serine/threonine kinase 1 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
BTBD17 | BTB (POZ) domain containing 17 | Predicted secreted proteins
| | | | | Tissue enriched |
C11orf87 | Chromosome 11 open reading frame 87 | Predicted membrane proteins
| | | | | Tissue enriched |
C1orf61 | Chromosome 1 open reading frame 61 | | | | | | Tissue enriched |
C1QL1 | Complement component 1, q subcomponent-like 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
C1QL2 | Complement component 1, q subcomponent-like 2 | Predicted secreted proteins
| | | | | Tissue enriched |
C1QL3 | Complement component 1, q subcomponent-like 3 | Predicted secreted proteins
| | | | | Tissue enriched |
C1QTNF4 | C1q and tumor necrosis factor related protein 4 | Predicted secreted proteins
| | | | | Tissue enriched |
C2orf80 | Chromosome 2 open reading frame 80 | | | | | | Tissue enriched |
C4orf50 | Chromosome 4 open reading frame 50 | | | | | | Tissue enriched |
C8orf46 | Chromosome 8 open reading frame 46 | | | | | | Tissue enriched |
CABP1 | Calcium binding protein 1 | Cytoskeleton related proteins Predicted secreted proteins
| | | | | Tissue enriched |
CACNA1E | Calcium channel, voltage-dependent, R type, alpha 1E subunit | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
CACNG2 | Calcium channel, voltage-dependent, gamma subunit 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CACNG3 | Calcium channel, voltage-dependent, gamma subunit 3 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CACNG7 | Calcium channel, voltage-dependent, gamma subunit 7 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CACNG8 | Calcium channel, voltage-dependent, gamma subunit 8 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CADM2 | Cell adhesion molecule 2 | Predicted membrane proteins
| | | | | Tissue enriched |
CAMKV | CaM kinase-like vesicle-associated | Enzymes
| | | | | Tissue enriched |
CASKIN1 | CASK interacting protein 1 | Plasma proteins
| | | | | Tissue enriched |
CBLN2 | Cerebellin 2 precursor | Predicted secreted proteins
| | | | | Tissue enriched |
CDH8 | Cadherin 8, type 2 | Predicted membrane proteins
| | | | | Tissue enriched |
CDK5R2 | Cyclin-dependent kinase 5, regulatory subunit 2 (p39) | | | | | | Tissue enriched |
CELF4 | CUGBP, Elav-like family member 4 | | | | | | Tissue enriched |
CELF5 | CUGBP, Elav-like family member 5 | | | | | | Tissue enriched |